Article from the leading publication Life Sciences Magazine featuring masitinib and its Phase 3 principal investigator, the neurologist Patrick Vermersch https://www.byteseu.com/798060/ #ABScience #AmyotrophicLateralSclerosis #BreakthroughTreatment #EuronextParis #InflammatoryDiseases #MastCells #microglia #MultipleSclerosis #neuroinflammation #Parkinson'sDisease #PATRICKVERMERSCH #Science